Naravela (Ethinylestradiol, Norgestimate)

Ethinylestradiol / Norgestimate, the active ingredient in Naravela, is a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Naravela as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naravela is a combined oral contraceptive used within the hormonal birth‑control pathway to prevent unintended pregnancy.

- Contraception: prevents pregnancy by inhibiting ovulation and altering cervical mucus. - Menstrual cycle regulation: helps achieve more regular menstrual periods. - Acne management: may improve hormone‑related acne in some women.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Spotting: irregular uterine bleeding, especially during the first cycles. - Mood changes: irritability or mild depressive symptoms. - Weight fluctuation: slight increase or decrease.

Serious or Rare Side Effects: - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Hypertension: sudden increase in blood pressure. - Liver dysfunction: jaundice or abnormal liver enzymes. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Visual disturbances: sudden loss of vision or eye pain. - Gallbladder disease: gallstones or cholecystitis.

Before using Naravela, consider the following precautions: - Smoking: avoid if over 35 years old due to increased cardiovascular risk. - Cardiovascular disease: contraindicated in patients with history of stroke, myocardial infarction, or uncontrolled hypertension. - Liver disease: use with caution in hepatic impairment. - Migraine with aura: may exacerbate symptoms; discuss alternatives with a clinician. - Breast cancer: not recommended for active or past estrogen‑sensitive malignancies. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Naravela may interact with several medicines; monitoring is essential.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may reduce effectiveness of anticoagulation. - Certain antiepileptics (e.g., carbamazepine, phenytoin): can lower contraceptive hormone levels. - Rifampin and other enzyme inducers: may diminish contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., fluconazole): may increase hormone concentrations. - Antibiotics (e.g., tetracycline): potential minor reduction in effectiveness. - St. John’s Wort: may modestly decrease hormone levels. - Selective serotonin reuptake inhibitors (SSRIs): monitor for mood changes.